23ANDME HOLDING CO
(NASDAQ: ME)

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in South San Francisco, CA.

0.498

-0.002 (-0.40%)
Range - - -   (-%)
Open -
Previous Close 0.500
Bid Price 2.180
Bid Volume 40
Ask Price 2.170
Ask Volume 31
Volume 708,813
Value -
Remark
Delayed prices. Updated at 02 May 2024 22:17.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis